SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-06-000063
Filing Date
2006-11-14
Accepted
2006-11-14 16:53:24
Documents
2
Period of Report
2006-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR EARNINGS RELEASE 3Q 2006 dorearnings3q2006.htm 8-K 21002
2 DOR PRESS RELASE EARNINGS 3Q 2006 pressreleaseearnings3q2006.htm EX-99.1 31401
  Complete submission text file 0000812796-06-000063.txt   54132
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 061216200
SIC: 2834 Pharmaceutical Preparations